- Home
- LOOP vs HOWL Comparison
LOOP vs HOWL Comparison
Compare LOOP & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOOP | HOWL |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.7M | 46.7M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LOOP | HOWL |
|---|---|---|
| Price | $0.41 | $0.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.55 | N/A |
| AVG Volume (30 Days) | 148.3K | ★ 601.6K |
| Earning Date | 10-20-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.27 | 18.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,889,000.00 | N/A |
| Revenue This Year | $109.05 | N/A |
| Revenue Next Year | $3,059.61 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7016.99 | N/A |
| 52 Week Low | $0.39 | $0.27 |
| 52 Week High | $1.99 | $1.83 |
Technical Indicators
Market Signals| Indicator | LOOP | HOWL |
|---|---|---|
| Relative Strength Index (RSI) | 34.96 | 62.45 |
| Support Level | $0.40 | $0.92 |
| Resistance Level | $0.56 | $0.99 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 20.19 | 91.22 |
Price Performance
Historical ComparisonAbout LOOP Loop Industries Inc.
Loop Industries Inc is a technology company whose mission is to accelerate the world's shift toward sustainable PET plastic and polyester fiber and away from dependence on fossil fuels. Loop Industries owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber, including plastic bottles, packaging, and textiles such as carpets and clothing, into its base building block monomers, DMT and MEG.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.